首页> 外国专利> Method and kit for detection of hemolytic uremic syndrome and necrotizing pneumonia in children with pneumococcal disease using serum fetuin-A levels as a biomarker

Method and kit for detection of hemolytic uremic syndrome and necrotizing pneumonia in children with pneumococcal disease using serum fetuin-A levels as a biomarker

机译:使用血清胎球蛋白-A水平作为生物标志物检测肺炎球菌病患儿的溶血性尿毒症综合征和坏死性肺炎的方法和试剂盒

摘要

The invention provides a method and a kit for measuring the levels of serum fetuin-A in children to reflect the severity of invasive pneumococcal diseases caused by Streptococcus pneumoniae, including necrotizing pneumonia and hemolytic uremic syndrome. The mean fetuin-A levels in the HUS patients are significantly lower (207±80 mg/L, p0.001) when compared to patients with lobar pneumonia (610±190 mg/L) and the healthy controls (630±250 mg/L). A serum fetuin-A level is a useful biomarker to classify the severity of pneumococcal infection in children. The level of biomarker fetuin-A can be monitored and evaluated by enzyme linked immunosorbent assay and Western blot hybridization.
机译:本发明提供了一种用于测量儿童血清中胎球蛋白-A水平以反映由肺炎链球菌引起的侵袭性肺炎球菌疾病的严重性的方法和试剂盒,包括坏死性肺炎和溶血性尿毒症综合征。与大叶性肺炎患者(610±190 mg / L)和健康对照组(630±250 mg / L)相比,HUS患者的平均胎球蛋白A水平显着降低(207±80 mg / L,p <0.001)。 L)。血清胎球蛋白A水平是分类儿童肺炎球菌感染严重程度的有用生物标志物。可以通过酶联免疫吸附测定和蛋白质印迹杂交来监测和评估生物标志物胎球蛋白-A的水平。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号